New Square Capital LLC Abb Vie Inc. Transaction History

New Square Capital LLC

$1.23 Billion
Q3 2024

A detailed history of New Square Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, New Square Capital LLC holds 1 shares of ABBV stock, worth $169. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 -0.0%

Holding current value

$169

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $57,736 - $67,423	-373 Reduced 99.73%	1 $0
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $3,516 - $4,006	-22 Reduced 5.56%	374 $68,000
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $6,192 - $6,973	-45 Reduced 10.2%	396 $61,000
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $8,816 - $10,206	-66 Reduced 13.02%	441 $65,000
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $45,053 - $56,066	-340 Reduced 40.14%	507 $68,000
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $45,696 - $52,626	316 Added 59.51%	847 $134,000
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $42,461 - $50,922	-307 Reduced 36.63%	531 $85,000
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $134 - $153	1 Added 0.12%	838 $112,000
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $4.28 Million - $5.44 Million	-31,093 Reduced 97.38%	837 $128,000
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $4.07 Million - $5.05 Million	30,866 Added 2900.94%	31,930 $5.18 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $517,636 - $587,594	-4,865 Reduced 82.05%	1,064 $115,000
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $23,040 - $25,668	219 Added 3.84%	5,929 $668,000
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $550,374 - $605,895	5,380 Added 1630.3%	5,710 $618,000
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $2,319 - $2,722	-27 Reduced 7.56%	330 $29,000
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $60,016 - $80,311	-818 Reduced 69.62%	357 $35,000
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $48,955 - $74,222	759 Added 182.45%	1,175 $90,000
Q2 2019 Aug 20, 2019	SELL	$65.7 - $83.98 $1.32 Million - $1.69 Million	-20,085 Reduced 97.97%	416 $30,000
Q1 2019 Apr 25, 2019	BUY	$77.14 - $90.79 $72,434 - $85,251	939 Added 4.8%	20,501 $1.65 Million
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $10,665 - $13,153	137 Added 0.71%	19,562 $1.8 Million
Q3 2018 Oct 19, 2018	BUY	$88.91 - $98.84 $118,161 - $131,358	1,329 Added 7.34%	19,425 $1.84 Million
Q2 2018 Jul 23, 2018	BUY	$89.78 - $106.23 $168,786 - $199,712	1,880 Added 11.59%	18,096 $1.61 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $31,375 - $42,014	-341 Reduced 2.06%	16,216 $1.54 Million
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $8,060 - $8,838	-90 Reduced 0.54%	16,557 $1.6 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $1.16 Million - $1.49 Million	16,647	16,647 $1.48 Million

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.

Account

New Square Capital LLC Abb Vie Inc. Transaction History